today announces two poster presentations at the European Society for Medical Oncology (ESMO)'s European Lung Cancer Congress 2025 (ELCC 2025). The studies demonstrate how Volition's Nu.Q ...
ELCC is a program of the European Society for Medical Oncology (ESMO ... M.D., CEO of MAIA. "Our poster features our latest findings on cytokine Interleukin-6 (IL-6) as a potential predictive ...
Poster highlights potential predictive ... ELCC is a program of the European Society for Medical Oncology (ESMO). "We are proud to join ELCC 2025, a premier conference focused directly on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback